Outcome of Board Meeting
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krishna Institute of Medical Sciences (KIMS) board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026. Consolidated revenue grew 23.4% to Rs 16,120 million from Rs 13,065 million. Profit after tax increased 38.3% to Rs 2,395 million from Rs 1,732 million. The auditors S.R. Batliboi & Associates LLP issued an unmodified (clean) opinion. The board appointed M/s. Sagar & Associates as Cost Auditors for FY 2026-27 and made senior management changes including a new CFO and Company Secretary re-designation. Mr. Adwik Bollineni was re-designated from Non-Executive to Executive Director. The 24th AGM is scheduled for August 27, 2026.
Strong financial performance with over 20% revenue growth and PAT growth exceeding 25% will be viewed positively by shareholders. Clean audit opinion and management changes provide stability. The company continues expanding with significant capital investments reflected in growing asset base.